Skip Navigation
Find a Doctor


Photo of Dr. Michael McDevitt

Michael Anthony McDevitt, M.D., Ph.D.

Assistant Professor of Medicine


Appointment Phone


Main Location

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »


  • Assistant Professor of Medicine
  • Assistant Professor of Oncology

Centers & Institutes



Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Appointment Phone: 410-955-3142

401 N. Broadway
Baltimore, MD 21231 map
Phone: 410-955-3142
Fax: 410-614-0854


Acute Myeloid Leukemia, Anemias, Atypical Chronic Myeloid Leukemia (aCML), Chronic Myelomonocytic Leukemia , Medical Oncology, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm (BCR-ABL Negative), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable , Myelodysplastic/Myeloproliferative Neoplasms, Myeloproliferative Disorders, Primary Myelofibrosis, Secondary Myelofibrosis, Thrombocytopenias

    Additional Information

  • Education +


    • Cornell University Medical College / MD (1989)


    • Johns Hopkins University School of Medicine / Medicine (1992)


    • Brigham and Women's Hospital / Hematology and Oncology (1996)
  • Research & Publications +

    Research Summary

    Dr. McDevitt's research focuses on unraveling the acquired genetic and epigenetic changes that lead to poor prognosis myeloid disorders. The long term goals include:

    1. Identify underlying pathways of deregulation to ultimately allow effective therapeutic targeting.
    2. Develop more sensitive and accurate biomarkers that improve diagnostic classification and prognostication and can be used in translational clinical trials.
    3. Apply these findings in early phase clinical trials for patients with accelerating myeloproliferative disorders and mixed myelodysplastic syndrome/myeloproliferative disorders. Of particular current interest are DNA repair pathways and Parp inhibitors.

    Key collaborators include Judith Karp, Keith Pratz, James Herman, Alison Moliterno, Doug Smith, Hetty Carraway, Steve Gore, Cliff Takemoto, Scott Kaufmann (Mayo Clinic), and Jaroslaw Maciejewski (Cleveland Clinic).

    Selected Publications

    1. Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP., Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2 and DNMT3A., Blood, 2011.
    2. Stein BL, Williams DM, O'Keefe C, Rogers O, Ingersoll RG, Spivak JL, Verma A, Maciejewski JP, McDevitt MA, Moliterno AR., Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes., Haematologica, 2011.
    3. Tiu RV, O'Keefe CL, Gondek LP, Huh J, Theil K, Mohamedali A, Advani AS, List A, Sekeres MA, McDevitt MA, Mufti G, Maciejewski JP, Prognostic impact of SNP array karyotyping in Myelodysplastic syndromes and related myeloid malignancies, BLOOD, 2011.
  • Academic Affiliations & Courses +
  • Activities & Honors +
  • Videos & Media +
Is This You? Edit Profile

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.